Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
27.15
-0.17 (-0.62%)
At close: Dec 31, 2025, 4:00 PM EST
27.68
+0.53 (1.95%)
After-hours: Dec 31, 2025, 7:40 PM EST
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $1.47 billion as of December 31, 2025. Its market cap has increased by 35.18% in one year.
Market Cap
1.47B
Enterprise Value
1.10B
1-Year Change
35.18%
Ranking
Category
Stock Price
$27.15
Market Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has increased from $393.35M to $1.47B, an increase of 272.99%. That is a compound annual growth rate of 193.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 1.47B | 66.51% |
| Dec 31, 2024 | 881.13M | 124.01% |
| Oct 11, 2024 | 393.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |